Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by BearDownAZon Apr 10, 2013 7:16am
345 Views
Post# 21235008

RE: RE: CUSIP for RVXCF

RE: RE: CUSIP for RVXCF

OK, I finally got the explanation from Etrade that I was looking for. I am satisfied and can now return my attention to the wait for ASSURE results at the end of June. Such a long while to wait. Hopefully Resverlogix team releases something interesting at the ATVB or Epigenetics meetings May 1-10, such as SUSTAIN full data set presentation or publication. Anyways, here is the response from Etrade:


Thank you for your message regarding the Reservlogix Corp Ord (RVX) shares that you have in your ETRADE Global Trading account. I am glad to assist you on this. I understand that shares of the security RVX are showing the US equivalent which is RVXCF in your account summary. I can confirm that these shares were purchased on the Toronto Stock Exchange and you can view this under Trading and Portfolios>>Global Trading>>Portfolios. Also, you will be able to check the corresponding trade for these under Trading and Portfolios>>Global Trading>>View Orders. It will show you the trades that you executed in this account and the corresponding global market involved. You also have the option to check your trade confirmations under your linked US brokerage account to confirm that there was no trade for RVXCF made. Additionally, monthly statements, trade confirmations and 1099 are considered official records therefore they will show the US equivalent which is reported to the IRS. 

Bullboard Posts